Who to treat due to high risk of bone fracture - The logic of the World Health Organization 2007 standpoint;Wskazania do leczenia osób z wysokim ryzykiem złamania kości - Logika stanowiska Światowej Organizacji Zdrowia wobec osteoporozy Anno 2007

Reumatologia

Volumn 45, Issue 5 SUPPL. 3, 2007, Pages

  Badurski, Janusz E ^a,d   Czerwiński, Edward ^a   Marcinowska Suchowierska, Ewa ^b   Tłustochowicz, Witold ^c  

^a Polska Fundacja Osteoporozy ^*

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c MILITARY INSTITUTE OF MEDICINE   (Poland)

^d Centrum Osteoporozy I Chorób Kostno Stawowych   (Poland)

Author keywords

Fracture risk factors; Intervention threshold; Osteoporosis

Indexed keywords

EID: 36549044382     PISSN: 00346233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report 843. World Health Organization, Geneva 1994.
2. Kanis JA, Borgstrom F, De Laet C, et al. Assessment of fracture risk. Osteoporos Int 2005; 16: 581-589.
3. Black DM. Revision of T-score BMD diagnostic thresholds. Osteoporos Int 2000; 11 Suppl. 2: S58.
4. Kanis JA, Glüer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int 2000; 11: 192-202.
5. Kanis JA. Diagnostic criteria for osteoporosis - where do we stand? Osteoporos Int 2001; 12 Suppl. 1: S1.
6. Badurski JE, Nowak NA, Dobreńko A i wsp. Przełomowy rok 2000 w dziedzinie osteoporozy: czy ważniejsze jest wypełnienie kryterium rozpoznania osteoporozy, czy rozpoznanie zagrożenia złamaniem? Postepy Osteoartrologii 2001; 12: 41-53.
7. Badurski JE. Zasady diagnostyki i leczenia osteoporozy i ryzyka złamań oraz leczenia farmakologicznego. Postepy Osteoartrologii 2001; 12 Supl. 1: 144-179.
8. Badurski JE. Co diagnozujemy i co leczymy - zagrożenie złamaniami czy "osteoporoze"? Postepy Osteoartrologii 2002; 13: 1-7.
9. Stanowisko Rady Naukowej Polskiej Fundacji Osteoporozy wobec diagnostyki i leczenia osteoporozy - czerwiec 2002. Postepy Osteoartrologii 2002; 13: 9-10.
10. Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001; 12: 989-995.
11. Nowak NA, Badurski JE, Supronik J i wsp. Epidemiologia osteoporozy u kobiet w aglomeracji Białegostoku (BOS), I: Gestość kości a złamania. Postepy Osteoartrologii 2003; 14: 1-5.
12. Siris ES, Chen YT, Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 2004; 164: 1108-1112.
13. Burger H, de Laet CE, van Daele PL, et al. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am J Epidemiol 2000; 147: 871-879.
14. Wainwright SA, Phipps KR, Stone JV, et al. A large proportion of fractures in postmenopausal women occur with baseline bone mineral density T-score ≥-2.5 [abstract]. J Bone Miner Res 2001; 16: S155.
15. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285: 785-795.
16. Kanis JA, Johnell O, De Laet C, et at. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004; 35: 375-382.
17. Kanis JA, Johansson H, Oden A, et al. A family history of fracture and fracture risk: a meta-analysis. Bone 2004; 35: 1029-1037.
18. Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004; 19: 893-899.
19. De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005; 16: 1330-1338.
20. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312: 1254-1259.
21. Kanis JA, Johnell O, Oden A, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int 2005; 16: 155-162.
22. Kanis JA, Johansson H, Johnell O, et al. Alcohol intake as a risk factor for fracture. Osteoporos Int 2005; 16: 737-742.
23. Dobreńko A, Badurski JE, Nowak NA, et al. Impact of BMD measurement in the evaluation of 10 years absolute risk of fracture and intervention threshold in postmenopausal women. A polish perspective. J Bone Mineral Res 2006; 21 Suppl. 1: S108.
24. Johnell O. When is intervention worthwhile in osteoporosis. Fifth Baltic Bone & Cartilage Conference in Naantali, Finland 2005.
25. Badurski JE, Dobreńko A, Nowak NA, et al. Bialystok Osteoporosis Study 2: One intervention threshold for all or age-dependent one. A simulate analysis. Osteoporos Int 2007; 18 Suppl. 1.
26. Doc.Ref.CPMP/EWP/552/95, Rev.2: Guideline on the evaluation of medicinal products in the treatment of primary osteoporosis. EMEA, London, 16 Nov 2006.
27. Boonen S, Body JJ, Boutsen Y, et al. Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int 2005; 16: 239-254.